BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11331873)

  • 21. Methylation and microRNA-mediated epigenetic regulation of SOCS3.
    Boosani CS; Agrawal DK
    Mol Biol Rep; 2015 Apr; 42(4):853-72. PubMed ID: 25682267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Naringenin Suppresses Neuroinflammatory Responses Through Inducing Suppressor of Cytokine Signaling 3 Expression.
    Wu LH; Lin C; Lin HY; Liu YS; Wu CY; Tsai CF; Chang PC; Yeh WL; Lu DY
    Mol Neurobiol; 2016 Mar; 53(2):1080-1091. PubMed ID: 25579382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of suppressors of cytokine signalling in human neoplasms.
    Sasi W; Sharma AK; Mokbel K
    Mol Biol Int; 2014; 2014():630797. PubMed ID: 24757565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SOCS proteins in regulation of receptor tyrosine kinase signaling.
    Kazi JU; Kabir NN; Flores-Morales A; Rönnstrand L
    Cell Mol Life Sci; 2014 Sep; 71(17):3297-310. PubMed ID: 24705897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simvastatin attenuates rhinovirus-induced interferon and CXCL10 secretion from monocytic cells in vitro.
    Wickert LE; Karta MR; Audhya A; Gern JE; Bertics PJ
    J Leukoc Biol; 2014 Jun; 95(6):951-9. PubMed ID: 24532643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Redox regulation of Janus kinase: The elephant in the room.
    Duhé RJ
    JAKSTAT; 2013 Oct; 2(4):e26141. PubMed ID: 24416654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human metapneumovirus inhibits the IL-6-induced JAK/STAT3 signalling cascade in airway epithelium.
    Mitzel DN; Jaramillo RJ; Stout-Delgado H; Senft AP; Harrod KS
    J Gen Virol; 2014 Jan; 95(Pt 1):26-37. PubMed ID: 24114793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SOCS proteins in development and disease.
    Trengove MC; Ward AC
    Am J Clin Exp Immunol; 2013; 2(1):1-29. PubMed ID: 23885323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stat3 and Socs3 expression patterns during murine placenta development.
    San Martin S; Fitzgerald JS; Weber M; Párraga M; Sáez T; Zorn TM; Markert UR
    Eur J Histochem; 2013 Jun; 57(2):e19. PubMed ID: 23807298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppressor of cytokine signaling 2 (SOCS2) associates with FLT3 and negatively regulates downstream signaling.
    Kazi JU; Rönnstrand L
    Mol Oncol; 2013 Jun; 7(3):693-703. PubMed ID: 23548639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A requirement for SOCS-1 and SOCS-3 phosphorylation in Bcr-Abl-induced tumorigenesis.
    Qiu X; Guo G; Chen K; Kashiwada M; Druker BJ; Rothman PB; Chen JL
    Neoplasia; 2012 Jun; 14(6):547-58. PubMed ID: 22787435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mammalian innate resistance to highly pathogenic avian influenza H5N1 virus infection is mediated through reduced proinflammation and infectious virus release.
    Nelli RK; Dunham SP; Kuchipudi SV; White GA; Baquero-Perez B; Chang P; Ghaemmaghami A; Brookes SM; Brown IH; Chang KC
    J Virol; 2012 Sep; 86(17):9201-10. PubMed ID: 22718824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SOCS, Inflammation, and Autoimmunity.
    Yoshimura A; Suzuki M; Sakaguchi R; Hanada T; Yasukawa H
    Front Immunol; 2012; 3():20. PubMed ID: 22566904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SOCS3 modulates interleukin-6R signaling preference in dermal fibroblasts.
    Luckett-Chastain LR; Ihnat MA; Mickle-Kawar BM; Gallucci RM
    J Interferon Cytokine Res; 2012 May; 32(5):207-15. PubMed ID: 22313262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tyrosine kinase gene fusions in cancer: translating mechanisms into targeted therapies.
    Medves S; Demoulin JB
    J Cell Mol Med; 2012 Feb; 16(2):237-48. PubMed ID: 21854543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of SOCS-1 Gene on Melanoma Cell Growth and Tumor Development.
    Scutti JA; Matsuo AL; Pereira FV; Massaoka MH; Figueiredo CR; Moreira DF; Belizário JE; Travassos LR
    Transl Oncol; 2011 Apr; 4(2):101-9. PubMed ID: 21461173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-17 enhancement of the IL-6 signaling cascade in astrocytes.
    Ma X; Reynolds SL; Baker BJ; Li X; Benveniste EN; Qin H
    J Immunol; 2010 May; 184(9):4898-906. PubMed ID: 20351184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor necrosis factor-a augments lipopolysaccharide-induced suppressor of cytokine signalling 3 (SOCS-3) protein expression by preventing the degradation.
    Dagvadorj J; Naiki Y; Tumurkhuu G; Noman AS; Iftakhar-E-Khuda I; Komatsu T; Koide N; Yoshida T; Takashi Yokochi
    Immunology; 2010 Jan; 129(1):97-104. PubMed ID: 20050332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SOCS3 deletion promotes optic nerve regeneration in vivo.
    Smith PD; Sun F; Park KK; Cai B; Wang C; Kuwako K; Martinez-Carrasco I; Connolly L; He Z
    Neuron; 2009 Dec; 64(5):617-23. PubMed ID: 20005819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new polycythaemia vera-associated SOCS3 SH2 mutant (SOCS3F136L) cannot regulate erythropoietin responses.
    Suessmuth Y; Elliott J; Percy MJ; Inami M; Attal H; Harrison CN; Inokuchi K; McMullin MF; Johnston JA
    Br J Haematol; 2009 Nov; 147(4):450-8. PubMed ID: 19735488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.